Regulation of NMDA receptor trafficking by amyloid-β
The DOI matches its Crossref record; 40 of the 41 references it cites were found in a registry or an index.
Abstract
Amyloid-beta peptide is elevated in the brains of patients with Alzheimer disease and is believed to be causative in the disease process. Amyloid-beta reduces glutamatergic transmission and inhibits synaptic plasticity, although the underlying mechanisms are unknown. We found that application of amyloid-beta promoted endocytosis of NMDA receptors in cortical neurons. In addition, neurons from a genetic mouse model of Alzheimer disease expressed reduced amounts of surface NMDA receptors. Reducing amyloid-beta by treating neurons with a gamma-secretase inhibitor restored surface expression of NMDA receptors. Consistent with these data, amyloid-beta application produced a rapid and persistent depression of NMDA-evoked currents in cortical neurons. Amyloid-beta-dependent endocytosis of NMDA receptors required the alpha-7 nicotinic receptor, protein phosphatase 2B (PP2B) and the tyrosine phosphatase STEP. Dephosphorylation of the NMDA receptor subunit NR2B at Tyr1472 correlated with receptor endocytosis. These data indicate a new mechanism by which amyloid-beta can cause synaptic dysfunction and contribute to Alzheimer disease pathology.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This synaptotoxicity is associated with a reduction in the surface expression of various receptor proteins, including those forming the N-methyl-D-aspartate receptors [26,27], which are critical for generation of long-term potentiation in hippocampal synapses.”
From Blocking the apoE/Aβ interaction ameliorates Aβ-related pathology in APOE ε2 and ε4 targeted replacement Alzheimer model mice (2014) · cites this paper as [27]
In the citing paper
“Oligomeric Aβ species have been shown to cause memory deficits in rodents [25] and are known for their synaptotoxic properties.”
From Blocking the apoE/Aβ interaction ameliorates Aβ-related pathology in APOE ε2 and ε4 targeted replacement Alzheimer model mice (2014) · cites this paper as [27]
In the citing paper
“It has been previously reported that extracellular application of Ab oligomers to primary neuronal cultures or organotypic hippocampal slices induce rapid changes in the structure and density of synaptic spines 47,48 and reduces expression of NMDARs and related synaptic proteins, 49 through several signaling pathways, one of which involves the a-7 nicotinic receptor.49”
From Blocking the Interaction between Apolipoprotein E and Aβ Reduces Intraneuronal Accumulation of Aβ and Inhibits Synaptic Degeneration (2013) · cites this paper as [49]
In the citing paper
“These cultures are characterized by progressive buildup of intraneuronal Ab, which is derived from endogenous Ab escaping exocytosis after cleavage of the APP SW mutant.9,49”
From Blocking the Interaction between Apolipoprotein E and Aβ Reduces Intraneuronal Accumulation of Aβ and Inhibits Synaptic Degeneration (2013) · cites this paper as [49]
In the citing paper
“Indeed Aβ production and amyloid production has been shown to reduce cell surface levels of other proteins including the NMDA receptor and the EphB2 receptor, both involved in synaptic plasticity [57], [58].”
From LDLR Expression and Localization Are Altered in Mouse and Human Cell Culture Models of Alzheimer's Disease (2010) · cites this paper as [57]
10 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
Alzheimer's Disease Is a Synaptic Failure
Selkoe, D. J. (2002) · Science · doi:10.1126/science.1074069 · Cited by 4,420
Terry, R. D., Masliah, E., Salmon, D. P., Butters, N., DeTeresa, R., Hill, R., Hansen, L. A., & Katzman, R. (1991) · Annals of Neurology · doi:10.1002/ana.410300410 · Cited by 4,397
In Vivo Protein Transduction: Delivery of a Biologically Active Protein into the Mouse
Schwarze, S. R., Ho, A., Vocero-Akbani, A., & Dowdy, S. F. (1999) · Science · doi:10.1126/science.285.5433.1569 · Cited by 2,416
CREB: A Stimulus-Induced Transcription Factor Activated by A Diverse Array of Extracellular Signals
Shaywitz, A. J., & Greenberg, M. E. (1999) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.68.1.821 · Cited by 2,134
APP Processing and Synaptic Function
Kamenetz, F., Tomita, T., Hsieh, H., Seabrook, G., Borchelt, D., Iwatsubo, T., Sisodia, S., & Malinow, R. (2003) · Neuron · doi:10.1016/s0896-6273(03)00124-7 · Cited by 1,644 · cited 1×
“Results Amyloid-β decreases surface expression of NMDA receptors Low amounts of secreted soluble amyloid-β regulate glutamatergic currents mediated by both NMDA and AMPA receptors without affecting GABA receptor current”
Ca2+ Influx Regulates BDNF Transcription by a CREB Family Transcription Factor-Dependent Mechanism
Tao, X., Finkbeiner, S., Arnold, D. B., Shaywitz, A. J., & Greenberg, M. E. (1998) · Neuron · doi:10.1016/s0896-6273(00)81010-7 · Cited by 1,561
Correlation Between Elevated Levels of Amyloid β-Peptide in the Brain and Cognitive Decline
Näslund, J. (2000) · JAMA · doi:10.1001/jama.283.12.1571 · Cited by 1,268
Reinsertion or Degradation of AMPA Receptors Determined by Activity-Dependent Endocytic Sorting
Ehlers, M. D. (2000) · Neuron · doi:10.1016/s0896-6273(00)00129-x · Cited by 1,096
Activity level controls postsynaptic composition and signaling via the ubiquitin-proteasome system
Ehlers, M. D. (2003) · Nature Neuroscience · doi:10.1038/nn1013 · Cited by 977
Cited by
Items 801–900 of 1,006
Noonan Syndrome-Associated SHP2 Dephosphorylates GluN2B to Regulate NMDA Receptor Function
Levy, A. D., Xiao, X., Shaw, J. E., Devi, S. P. S., Katrancha, S. M., Bennett, A. M., Greer, C. A., Howe, J. R., Machida, K., & Koleske, A. J. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.07.006 · Cited by 36
“Y1472 is primarily dephosphorylated by STEP (Snyder et al., 2005).”
InfluentialLi, T., Jiao, J.-J., Su, Q., Hölscher, C., Zhang, J., Yan, X.-D., Zhao, H.-M., Cai, H.-Y., & Qi, J.-S. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2020.108042 · Cited by 36
Samanta, S., Rajasekhar, K., Ramesh, M., Murugan, N. A., Alam, S., Shah, D., Clement, J. P., & Govindaraju, T. (2021) · Advanced Therapeutics · doi:10.1002/adtp.202000225 · Cited by 36
Significant structural but not physiological changes in cortical neurons of 12-month-old Tg2576 mice
Rocher, A. B., Kinson, M. S., & Luebke, J. I. (2008) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.07.014 · Cited by 41
“…spines (Lacor et al., 2004; Shankar et al., 2007) and have been demonstrated, in vitro , to cause spine regression by reducing the expression NMDA receptors (Snyder et al., 2005; Lacor et al. 2007) and by reducing calcium in fl ux through the NMDA receptors present on spines (Shankar et al., 2007).”
InfluentialThe galanin receptor 2/3 agonist Gal2‐11 protects the SN56 cells against β‐amyloid25–35 toxicity
Pirondi, S., Giuliani, A., Vecchio, G. D., Giardino, L., Hökfelt, T. G. M., & Calzà, L. (2009) · Journal of Neuroscience Research · doi:10.1002/jnr.22278 · Cited by 35
“A growing body of literature suggests an active role of such compounds in b-amyloid toxicity (Snyder et al., 2005; Heinitz et al., 2006; Shankar et al., 2007).”
Factors affecting the GABAergic synapse function in Alzheimer’s disease: Focus on microRNAs
Rivera, J., Sharma, B., Torres, M. M., & Kumar, S. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.102123 · Cited by 39
Deb, I., Poddar, R., & Paul, S. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.07165.x · Cited by 39
Self-citationYoshino, Y., Ishisaka, M., Tsujii, S., Shimazawa, M., & Hara, H. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.01.098 · Cited by 36
“It had been reported that Ab causes neuronal cell death via the inducting of mitochondrial dysfunction [5], unfolded protein response [6e9], synaptic dysfunction [10], and activation of glia cells [11].”
Leuba, G., Vernay, A., Kraftsik, R., Tardif, É., Riederer, B. M., & Savioz, A. (2014) · Current Alzheimer Research · doi:10.2174/15672050113106660170 · Cited by 38
“Thus, Aß might influence the internalization of GluN2B but not of GluN1 subunit [14], leading to a decreased expression in GluN2B without decrease in GluN1, as in our human data.”
BackgroundResultDopamine agonists rescue Aβ–induced LTP impairment by Src-family tyrosine kinases
Yuanxiang, P., Janc, O. A., Grochowska, K. M., Kreutz, M. R., & Reymann, K. G. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.01.008 · Cited by 37
“, 2012) and involves among other N-methyl-D-aspartate subtype glutamate receptor (NMDAR) and their downstream signaling pathways (Rönicke et al., 2011; Shankar et al., 2007; Snyder et al., 2005).”
BackgroundIqbal, J., Zhang, K., Jin, N., Zhao, Y., Liu, Q., Ni, J., & Shen, L. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00034 · Cited by 36
Baguley, T. D., Xu, H., Chatterjee, M., Nairn, A. C., Lombroso, P. J., & Ellman, J. A. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm401037h · Cited by 35
Self-citationNeuroprotective effect of TNFα against the β-amyloid neurotoxicity mediated by CDK5 kinase
Orellana, D. I., Quintanilla, R. A., & Maccioni, R. B. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2006.10.010 · Cited by 36
“Nevertheless, in our studies we used soluble Aβ42 which ismuch more susceptible to aggregation than Aβ40, and is much more toxic than the other forms of Aβ peptide [30,34].”
MethodFavre-Besse, F.-C., Poirel, O., Bersot, T., Kim-Grellier, E., Daumas, S., Mestikawy, S. E., Acher, F., & Pietrancosta, N. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.03.056 · Cited by 34
Misfolding of Amyloidogenic Proteins and Their Interactions with Membranes
Relini, A., Marano, N., & Gliozzi, A. (2013) · Biomolecules · doi:10.3390/biom4010020 · Cited by 34
“through endocytosis of NMDA receptors [228].”
Huang, Y. Y., Zhang, H., Yang, S., Qiao, H., Zhou, W., & Zhang, Y. (2012) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2012.01.030 · Cited by 36
Caspase activation without apoptosis: insight into Aβ initiation of neurodegeneration
Hyman, B. T. (2010) · Nature Neuroscience · doi:10.1038/nn0111-5 · Cited by 40
Modulatory Activity of Soluble Beta Amyloid on HPA Axis Function in Rats
Morgese, M. G., Tucci, P., Colaianna, M., Zotti, M., Cuomo, V., Schiavone, S., & Trabace, L. (2014) · Current Pharmaceutical Design · doi:10.2174/13816128113199990500 · Cited by 36
Isoflurane anesthesia in aged mice and effects of A1 adenosine receptors on cognitive impairment
Zuo, C., Wang, C., Liu, J., Shen, T., Zhou, J., Hao, X., Pan, Y., Liu, H., Lian, Q., & Lin, H. (2018) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12794 · Cited by 36
Chen, G., Liu, C., Meng, G., Zhang, C., Chen, F., Tang, S., Hong, H., & Zhang, C. (2018) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.13056 · Cited by 36
“[1,2] Abnormal expression and accumulation of amyloid b-peptide (Ab) in brain tissues are the main causes of AD.”
BackgroundResultInfluentialToffa, D. H., Magnerou, M. A., Kassab, A., Djibo, F. H., & Sow, A. D. (2019) · Neurochemistry International · doi:10.1016/j.neuint.2019.03.014 · Cited by 35
Ochiishi, T., Kaku, M., Kiyosue, K., Doi, M., Urabe, T., Hattori, N., Shimura, H., & Ebihara, T. (2019) · Scientific Reports · doi:10.1038/s41598-019-53415-8 · Cited by 34
Flores‐Muñoz, C., Gómez, B., Mery, E., Mujica, P., Gajardo, I., Córdova, C., López-Espíndola, D., Duran-Aniotz, C. A., Hetz, C. A., Muñoz, P., et al. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.00046 · Cited by 37
“…morphology (Hsieh et al., 2006; Lacor et al., 2007; Shankar, 2007; Price et al., 2014) and glutamate receptor trafficking, expression and function (Snyder et al., 2005; Hsieh et al., 2006; Shankar, 2007; Miñano-Molina et al., 2011; Ardiles et al., 2012), and consequently, impair excitatory…”
BackgroundReal-time nanoscale organization of amyloid precursor protein
Kedia, S., Ramakrishna, P., Netrakanti, P. R., Jose, M., Sibarita, J., Nadkarni, S., & Nair, D. K. (2020) · Nanoscale · doi:10.1039/d0nr00052c · Cited by 36
Opsomer, R., Contino, S., Perrin, F., Gualdani, R., Tasiaux, B., Doyen, P. J., Vergouts, M., Vrancx, C., Doshina, A., Pierrot, N., et al. (2020) · eNeuro · doi:10.1523/eneuro.0322-19.2020 · Cited by 40
Tang, Y., Ye, M., Du, Y., Qiu, X., Lv, X., Yang, W., & Luo, J. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.07.021 · Cited by 36
Kohno, M., Horibe, T., Ohara, K., Ito, S., & Kawakami, K. (2014) · Chemistry & Biology · doi:10.1016/j.chembiol.2014.09.008 · Cited by 37
“…in particular, LRP1, RAGE, a7 nicotinic acetylcholine receptor, N-methyl-D-aspartic acid (NMDA) receptor, methanotrophic glutamate receptor, and p75 neurotrophin receptor (Takuma et al., 2009; Deane et al., 2004; Snyder et al., 2005; Renner et al., 2010; Nagele et al., 2002; Yamamoto et al., 2007).”
BackgroundDoes the term ‘trophic’ actually mean anti-amyloidogenic? The case of NGF
Calissano, P., Amadoro, G., Matrone, C., Ciafrè, S., Marolda, R., Corsetti, V., Ciotti, M. T., Mercanti, D., Luzio, A. D., Severini, C., et al. (2010) · Cell Death and Differentiation · doi:10.1038/cdd.2010.38 · Cited by 39
Excitatory synaptic transmission is depressed in cultured hippocampal neurons of APP/PS1 mice
Priller, C., Mitteregger, G., Paluch, S., Vassallo, N., Staufenbiel, M., Kretzschmar, H. A., Jucker, M., & Herms, J. W. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.10.016 · Cited by 38
Miyamoto, T., Kim, D., Knox, J. A., Johnson, E., & Mucke, L. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.666529 · Cited by 33
Toledo, J. P., Fernández-Pérez, E. J., Ferreira, I. L., Marinho, D., Riffo-Lepe, N., Pineda-Cuevas, B. N., Pinochet-Pino, L. F., Burgos, C. F., Rego, A. C., & Aguayo, L. G. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.617821 · Cited by 54
“Alzheimer’s Disease (AD) is the most prevalent neurodegenerative disorder characterized by cognitive and behavioral deficits (Terry et al., 1991) that is expected to reach 82 million cases in 2030 (Weidner and Barbarino, 2019).”
BackgroundXu, Y., Cui, C., Pang, C., Christen, Y., & Luo, Y. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2007.05905.x · Cited by 35
“Several notable results from the recent studies demonstrated that Ab modulated NMDA receptors, LTP and NO ⁄ cGMP ⁄ CREB signaling pathway (Vitolo et al., 2002; Snyder et al., 2005; Puzzo et al., 2005; De Felice et al., 2007).”
Hoey, S. E., Buonocore, F., Cox, C. J., Hammond, V. J., Perkinton, M. S., & Williams, R. J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0078155 · Cited by 36
Omata, Y., Thanasegaran, S., Lim, Y., Yamasaki, Y., Ishigaki, Y., Tatsuno, T., Maruyama, M., & Tsuda, L. (2016) · Aging · doi:10.18632/aging.100899 · Cited by 34
“Aβ appears to produce neuronal toxicity through binding neuronal receptors, such as the prion-receptor, metabotropic glutamate receptors or N-methyl-Daspartate receptors [11-13].”
Motaghinejad, M., Motevalian, M., & Fatima, S. (2017) · Life Sciences · doi:10.1016/j.lfs.2017.01.002 · Cited by 36
Martín‐Belmonte, A., Aguado, C., Alfaro‐Ruiz, R., Itakura, M., Moreno‐Martínez, A. E., de la Ossa, L., Molnár, E., Fukazawa, Y., & Luján, R. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.577996 · Cited by 37
“Our data differs from other studies using different mouse models of AD reporting down-regulation of the protein for AMPAR subunits (Snyder et al., 2005; Baglietto-Vargas et al., 2018; Li et al., 2019).”
ResultHong, Z., Yu, S., Wang, Z., & Zhu, Y. Z. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms160818544 · Cited by 36
“CREB is required for the formation of long-term memory and decrease in CREB phosphorylation was reported to precede morphological alterations in AD models [8–10].”
Neurogranin restores amyloid β-mediated synaptic transmission and long-term potentiation deficits
Kaleka, K. S., & Gerges, N. Z. (2015) · Experimental Neurology · doi:10.1016/j.expneurol.2015.12.013 · Cited by 34
Role of Striatal-Enriched Tyrosine Phosphatase in Neuronal Function
Kamceva, M., Benedict, J., Nairn, A. C., & Lombroso, P. J. (2016) · Neural Plasticity · doi:10.1155/2016/8136925 · Cited by 35
“In AD, abnormally high levels of Aβ bind to and activate α7nAChRs [67–70], causing calcium influx and activation of calcineurin and PP1 and the dephosphorylation of STEP at the regulatory serine site within the KIMdomain [10].”
BackgroundInfluentialSelf-citationMechanisms of Neural and Behavioral Dysfunction in Alzheimer’s Disease
Wesson, D. W., Nixon, R. A., Levy, E., & Wilson, D. A. (2011) · Molecular Neurobiology · doi:10.1007/s12035-011-8177-1 · Cited by 34
“Across all of these models, the internalization of membrane-bound NMDA receptors reduces the strength of the synapse and its ability to express NMDA-dependent plasticity, impacting normal cell–cell communication [86].”
Resting and Active States of the ERK2:HePTP Complex
Francis, D. M., Różycki, B., Tortajada, A., Hummer, G., Peti, W., & Page, R. (2011) · Journal of the American Chemical Society · doi:10.1021/ja2075136 · Cited by 32
Mahaman, Y. A. R., Huang, F., Salissou, M. T. M., Yacouba, M. B. M., Wang, J., Liu, R., Zhang, B., Li, H., Zhu, F., & Wang, X. (2023) · Neurotherapeutics · doi:10.1007/s13311-023-01356-6 · Cited by 35
Dual impact of neuroinflammation on cognitive and motor impairments in Alzheimer's disease
Fakorede, S., Lateef, O. M., Garuba, W. A., Akosile, P. O., Okon, D. A., & Aborode, A. T. (2025) · Journal of Alzheimer s Disease Reports · doi:10.1177/25424823251341870 · Cited by 57
“96 Furthermore, mitochondrial dysfunction, another result of neuroin fl ammation, contributes to ROS production, destabilizing NMDA receptors and causing excitotoxicity.”
Hunter, S., & Brayne, C. (2012) · Alzheimer s Research & Therapy · doi:10.1186/alzrt108 · Cited by 33
STEP inhibition reverses behavioral, electrophysiologic, and synaptic abnormalities in Fmr1 KO mice
Chatterjee, M., Kurup, P. K., Lundbye, C. J., Toft, A. K. H., Kwon, J., Benedict, J., Kamceva, M., Banke, T. G., & Lombroso, P. J. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.09.026 · Cited by 35
“neurodegenerative disorders including Alzheimer's disease (AD) (Snyder et al., 2005; Zhang et al., 2010), Parkinson's disease (Kurup et al.”
Self-citationNeuronal pentraxin 1: A synaptic-derived plasma biomarker in Alzheimer's disease
Ma, Q.-L., Teng, E., Zuo, X., Jones, M., Teter, B., Zhao, E. Y., Zhu, C., Bilousova, T., Gylys, K. H., Apostolova, L. G., et al. (2018) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.02.014 · Cited by 32
Griffin, E. F., Yan, X., Caldwell, K. A., & Caldwell, G. A. (2018) · Human Molecular Genetics · doi:10.1093/hmg/ddy308 · Cited by 36
Circuitry and Synaptic Dysfunction in Alzheimer’s Disease: A New Tau Hypothesis
Mondragón‐Rodríguez, S., Salgado, H., & Peña‐Ortega, F. (2020) · Neural Plasticity · doi:10.1155/2020/2960343 · Cited by 38
Synaptic Disruption by Soluble Oligomers in Patients with Alzheimer’s and Parkinson’s Disease
Gutierrez, B. A., & Limón, A. (2022) · Biomedicines · doi:10.3390/biomedicines10071743 · Cited by 34
Decourt, B., Noorda, K., Noorda, K. J., Shi, J., & Sabbagh, M. N. (2022) · Journal of Experimental Pharmacology · doi:10.2147/jep.s265626 · Cited by 34
Regulation of NMDA Receptors by Kinases and Phosphatases
Salter, M. W., Dong, Y., Kalia, L. V., Liu, X. J., & Pitcher, G. M. (2009) · Europe PMC (PubMed Central) · Cited by 40
Self-citationCentaurin-α1-Ras-Elk-1 Signaling at Mitochondria Mediates β-Amyloid-Induced Synaptic Dysfunction
Szatmari, E. M., Oliveira, A. F., Sumner, E. J., & Yasuda, R. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.2641-12.2013 · Cited by 33
Mosley, C. A., Myers, S. J., Murray, E. E., Santangelo, R., Tahirovic, Y. A., Kurtkaya, N. L., Mullasseril, P., Yuan, H., Lyuboslavsky, P. N., Le, P., et al. (2009) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2009.05.085 · Cited by 32
Majdi, M., Ribeiro‐da‐Silva, A., & Cuello, A. C. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.11.034 · Cited by 39
Lee, H., Lee, E., Song, Y. S., & Kim, E. (2013) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2013.0158 · Cited by 35
Pathway-Specific Alteration of Synaptic Plasticity in Tg2576 Mice
Jung, J. H., An, K., Kwon, O. B., Kim, H.-S., & Kim, J.-H. (2011) · Molecules and Cells · doi:10.1007/s10059-011-0077-8 · Cited by 33
“…alterations in synaptic transmission, presumably due to various underlying causes (defects of synaptic development, presynaptic release probability changes, or abnormal trafficking of postsynaptic receptors) (Almeida et al., 2005; Moreno et al., 2009; Saura et al., 2004; Snyder et al., 2005).”
Inverse correlation between amyloid precursor protein and synaptic plasticity in transgenic mice
Matsuyama, S., Teraoka, R., Mori, H., & Tomiyama, T. (2007) · NeuroReport · doi:10.1097/wnr.0b013e3281e72b18 · Cited by 32
To be or not to be toxic: aggregations in Huntington and Alzheimer disease
Slow, E., Graham, R. K., & Hayden, M. R. (2006) · Trends in Genetics · doi:10.1016/j.tig.2006.05.008 · Cited by 36
Reelin-mediated Signaling during Normal and Pathological Forms of Aging.
Doehner, J., & Knuesel, I. (2010) · Europe PMC (PubMed Central) · Cited by 42
Braithwaite, S. P., Xu, J., Leung, J., Urfer, R., Nikolich, K., Oksenberg, D., Lombroso, P. J., & Shamloo, M. (2008) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2008.06209.x · Cited by 31
“, 2007) as well as pathological states including Alzheimer’s disease (Snyder et al., 2005) and epilepsy (Choi et al.”
InfluentialSelf-citationAmyloid Precursor Protein (APP) and GABAergic Neurotransmission
Tang, B. L. (2019) · Cells · doi:10.3390/cells8060550 · Cited by 38
On the Common Journey of Neural Cells through Ischemic Brain Injury and Alzheimer’s Disease
Kriška, J., Heřmanová, Z., Knotek, T., Turečková, J., & Anděrová, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22189689 · Cited by 35
“Additionally, the activation of the α7 nicotinic acetylcholine receptors (α7-nAcChRs), metabotropic glutamate receptors (mGluRs), or perisynaptic NMDARs results in the LTD facilitation via calcineurin-STEP-cofilin, mitogen-activated serine/threonine protein kinase p38 MAPK (p38 MAPK), and glycogen synthase kinase 3β (…”
BackgroundNeuroprotective effects of riluzole in Alzheimer's disease: A comprehensive review
Golmohammadi, M., Mahmoudian, M., Hasan, E. K., Alshahrani, S. H., Romero‐Parra, R. M., Malviya, J., Hjazi, A. M., Najm, M. A. A., Almulla, A. F., Zamanian, M. Y., et al. (2023) · Fundamental and Clinical Pharmacology · doi:10.1111/fcp.12955 · Cited by 34
“Over-stimulation of extrasynaptic NMDA receptors [94] and extreme reduction of synaptic NMDA receptors [95] can increase A β release [96].”
Leclerc, E., Sturchler, E., Vetter, S. W., & Heizmann, C. W. (2009) · Reviews in the Neurosciences · doi:10.1515/revneuro.2009.20.2.95 · Cited by 32
Protein-Protein Interactions and Aggregation Inhibitors in Alzheimer’s Disease
Ganeshpurkar, A., Swetha, R., Kumar, D., Gangaram, G. P., Singh, R., Gutti, G., Jana, S., Kumar, D., Kumar, A., & Singh, S. K. (2019) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026619666190304153353 · Cited by 30
Dinamarca, M. C., Luca, M. D., Godoy, J. A., & Inestrosa, N. C. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.08.107 · Cited by 32
“In the case of NMDAR, Abo induce receptor internalization and deregulation of these signaling pathway [9,10].”
Karasawa, T., & Lombroso, P. J. (2014) · Neuroscience Research · doi:10.1016/j.neures.2014.08.018 · Cited by 32
Self-citationHuang, H., Chang, P., Lu, S., Zheng, B.-W., & Jiang, Z.-F. (2015) · Journal of Receptors and Signal Transduction · doi:10.3109/10799893.2015.1006331 · Cited by 34
“In addition, there is a suggestion that Ab might result in the endocytosis of NMDA receptor (27); however, it is unclear whether the endocytosis of NMDA receptor will make a negative feedback to the homeostasis on glutamate and GABA.”
Xu, J., Kurup, P. K., Baguley, T. D., Foscue, E. P., Ellman, J. A., Nairn, A. C., & Lombroso, P. J. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-2057-1 · Cited by 31
Self-citationDrebrin in Alzheimer’s Disease
Ishizuka, Y., & Hanamura, K. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-4-431-56550-5_12 · Cited by 35
Burns, L. H., & Wang, H.-Y. (2017) · Neuroimmunology and Neuroinflammation · doi:10.20517/2347-8659.2017.50 · Cited by 34
“Because α7nAChR is an upstream regulator of the N-methyl-D-aspartate receptor (NMDAR)[53,54], the impaired NMDAR signaling in AD brain and 3xTg AD mice is very likely related to the impaired signaling via α7nAChR.”
InfluentialA metabolic perspective of late onset Alzheimer’s disease
Ettcheto, M., Cano, A. C., Busquets, O., Manzine, P. R., Sánchez‐López, E., Castro-Torres, R. D., Beas‐Zárate, C., Verdaguer, E., García, M. L., Olloquequi, J., et al. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.104255 · Cited by 34
Kim, K., Shin, W., Kang, M., Lee, S., Kim, D., Kang, R., Jung, Y., Cho, Y., Yang, E., Kim, H., et al. (2020) · eLife · doi:10.7554/elife.54224 · Cited by 30
Avchalumov, Y., Oliver, R. J., Trenet, W., Osorno, R. E. H., Sibley, B. D., Purohit, D. C., Contet, C., Roberto, M., Woodward, J. J., & Mandyam, C. D. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2020.108438 · Cited by 31
“[PubMed: 25120075] McQuate A, Latorre-Esteves E & Barria A (2017) A Wnt/Calcium Signaling Cascade Regulates Neuronal Excitability and Trafficking of NMDARs.”
BackgroundWilke, S. A., Raam, T., Antonios, J. K., Bushong, E. A., Koo, E. H., Ellisman, M. H., & Ghosh, A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0084349 · Cited by 36
“A number of previous studies have identified a decrease in synapse density and a reduction in synaptic strength in the hippocampus of FAD mutant mice [5,6,8,10,40,41].”
Yang, C. H., Huang, C., & Hsu, K. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.5902-11.2012 · Cited by 33
Gardner, L. E., White, J. D., Eimerbrink, M. J., Boehm, G. W., & Chumley, M. J. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2016.06.007 · Cited by 29
Fluid Biomarkers in Clinical Trials of Alzheimer’s Disease Therapeutics
Ritter, A. R., & Cummings, J. L. (2015) · Frontiers in Neurology · doi:10.3389/fneur.2015.00186 · Cited by 34
“Aβ oligomers are neurotoxic and have been shown to inhibit memory, disrupt long-term potentiation, and impair synaptic function in animal models (21, 22).”
Synthesized Aβ42 Caused Intracellular Oxidative Damage, Leading to Cell Death, via Lysosome Rupture
Oku, Y., Murakami, K., Irie, K., Hoseki, J., & Sakai, Y. (2017) · Cell Structure and Function · doi:10.1247/csf.17006 · Cited by 29
“Intracellular accumulation of Aβ42 in APP transgenic mice was reported to cause lysosomal and endosomal leakage (Almeida et al., 2006; Umeda et al., 2011).”
Orr, A. L., Hanson, J. E., Li, D., Klotz, A., Wright, S., Schenk, D., Seubert, P., & Madison, D. V. (2014) · Neuron · doi:10.1016/j.neuron.2014.04.039 · Cited by 29
Changes in the physiology of CA1 hippocampal pyramidal neurons in preplaque CRND8 mice
Wykes, R. C., Kalmbach, A., Eliava, M., & Waters, J. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.05.001 · Cited by 34
“The AMPA/NMDA ratio is likely to change if Aβ has selective effects on synaptic AMPA or NMDA receptors, as has been suggested in other mouse models of APP overexpression and following application of Aβ oligomers (Snyder et al., 2005).”
BackgroundStriatal-Enriched Protein Tyrosine Phosphatase in Alzheimer’s Disease
Xu, J., Kurup, P. K., Nairn, A. C., & Lombroso, P. J. (2012) · Advances in pharmacology · doi:10.1016/b978-0-12-394816-8.00009-x · Cited by 32
“As discussed in the following sections, Aβ peptide binds to α7 nicotinic acetylcholine receptors (α7 nAChRs) that in turn lead to the activation of PP2B and STEP dephosphorylation (Snyder et al., 2005).”
InfluentialSelf-citationForest, K. H., Alfulaij, N., Arora, K., Taketa, R., Sherrin, T., Todorovic, C., Lawrence, J. L. M., Yoshikawa, G. T., Ng, H. L., Hruby, V. J., et al. (2017) · Journal of Neurochemistry · doi:10.1111/jnc.14257 · Cited by 33
The Tyrosine Phosphatase STEP Is Involved in Age-Related Memory Decline
Castonguay, D., Dufort‐Gervais, J., Ménard, C., Chatterjee, M., Quirion, R., Bontempi, B., Schneider, J. S., Arnsten, A. F. T., Nairn, A. C., Norris, C. M., et al. (2018) · Current Biology · doi:10.1016/j.cub.2018.02.047 · Cited by 32
Self-citationThe STEP 61 interactome reveals subunit-specific AMPA receptor binding and synaptic regulation
Won, S., Incontro, S., Li, Y., Nicoll, R. A., & Roche, K. W. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1900878116 · Cited by 33
Marcantoni, A., Cerullo, M. S., Buxeda, P., Tomagra, G., Giustetto, M., Chiantia, G., Carabelli, V., & Carbone, E. (2020) · The Journal of Physiology · doi:10.1113/jp279345 · Cited by 29
“Specifically, Abeta oligomers affect Ca 2+ entry through NMDARs (Snyder et al. , 2005; Zhang et al. , 2016) and/or voltage-gated calcium channels (VGCCs) (Nimmrich et al. , 2008; Thibault et al. , 2012; Wang & Mattson, 2013).”
The role of STEP in Alzheimer's disease
Kurup, P. K., Zhang, Y., Venkitaramani, D. V., Xu, J., & Lombroso, P. J. (2010) · Channels · doi:10.4161/chan.4.5.12910 · Cited by 29
“Knocking down STEP with interfering RNA increases NMDAR trafficking to synaptic membranes.4,8 A previous study suggested that Aβ leads to the activation of STEP through a calcineurin-mediated pathway, which subsequently increased internalization of surface NMDAR.4 A recent study has demonstrated that STEP is also regu…”
InfluentialSelf-citationSpires‐Jones, T. L., & Hannan, A. J. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04275.x · Cited by 34
Zhang, L., Xie, J., Yang, J., & Cao, Y. (2013) · Journal of Neuroscience Research · doi:10.1002/jnr.23263 · Cited by 28
“, 2003), possibly through Ab-mediated internalization of N-methyl-D-aspartate (NMDA) receptors (Snyder et al., 2005).”
InfluentialUbiquitin-Proteasome System Inhibition Promotes Long-Term Depression and Synaptic Tagging/Capture
Li, Q., Körte, M., & Sajikumar, S. (2015) · Cerebral Cortex · doi:10.1093/cercor/bhv084 · Cited by 32
“STEP is a brain-specific tyrosine phosphatase that modulates N-methyl--aspartate receptor (NMDAR) trafficking which then regulates LTP (Snyder et al. 2005; Braithwaite et al. 2006).”
The Role of Synaptic Dysfunction in Alzheimer’s Disease
Pei, Y. A., Davies, J., Zhang, M., & Zhang, H. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-191334 · Cited by 31
Li, W., Kutas, M., Gray, J. A., Hagerman, R. J., & Olichney, J. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.09.023 · Cited by 28
In the fast lane: Receptor trafficking during status epilepticus
Naylor, D. E. (2023) · Epilepsia Open · doi:10.1002/epi4.12718 · Cited by 33
Alipourfard, F., Shajiee, H., Nazari-Serenjeh, F., Hojati, V., & Alirezaie, M. (2023) · Research in Pharmaceutical Sciences · doi:10.4103/1735-5362.371583 · Cited by 31
“Aß peptides also increase Nmethyl-D-aspartate (NMDA) receptormediated calcium influx leading to excitotoxicity and oxidative damage (26-28).”
Yang, W., Ma, K., Qian, Y., Zhang, J.-S., Feng, G.-F., Shi, L., Zhang, Z., & Liu, Z. (2015) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2015.04.013 · Cited by 30
The tyrosine phosphatase STEP constrains amygdala-dependent memory formation and neuroplasticity
Olausson, P., Venkitaramani, D. V., Moran, T. D., Salter, M. W., Taylor, J. R., & Lombroso, P. J. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.07.069 · Cited by 28
“Additionally, STEP dephosphorylation promotes internalization of NR1/NR2B receptors (Snyder et al., 2005) and GluR1/GluR2containing AMPARs (Zhang et al.”
Self-citationPellistri, F., Bucciantini, M., Invernizzi, G., Gatta, E., Penco, A., Frana, A. M., Nosi, D., Relini, A., Regonesi, M. E., Gliozzi, A., et al. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2013.08.019 · Cited by 33
“These findings suggest that these oligomers do not affect receptor trafficking by endocytosis, as reported in cells exposed to other pre-fibrillar assemblies [40–42], leaving substantially unchanged receptor abundance on the cell membrane.”
Willén, K. I., Sroka-Oleksiak, A., Takahashi, R. H., & Gouras, G. K. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170262 · Cited by 29
“Further evidence for such selectivity of A came from a report showing that not all neurons are equally sensitive to A -induced synapse damage [21].”
Self-citationSrivastava, P. K., Roncon, P., Łukasiuk, K., Gorter, J. A., Aronica, E., Pitkänen, A., Petretto, E. G., Johnson, M. R., & Simonato, M. (2017) · eNeuro · doi:10.1523/eneuro.0152-17.2017 · Cited by 27
“Ptpn5 can also target the glutamate receptor subunits GluN2b and GluA2 leading to receptor internalization and decreased synaptic efficiency (Snyder et al., 2005; Xu et al., 2009).”
Metadata
- Authors
- Snyder, E. M., Nong, Y., Almeida, C. G., Paul, S., Moran, T., Choi, E. Y., Nairn, A. C., Salter, M. W., Lombroso, P. J., Gouras, G. K., & Greengard, P.
- Affiliations
- Rockefeller University (US)
- Hospital for Sick Children (CA)
- Yale University (US)
- Cornell University (US)
- Corresponding author
- Snyder, Eric M
- Venue
- Nature Neuroscience
- Published
- 2005-07-17
- Volume
- 8
- Issue
- 8
- Pages
- 1051-1058
- ISSN
- 1097-6256 (ISSN-L)
- 1546-1726
- OpenAlex
- W1980750700
- Cited by
- 1,561
- References
- 41
- Citations by year
- 2026: 25 · 2025: 38 · 2024: 43 · 2023: 50 · 2022: 54 · 2021: 80 · 2020: 75 · 2019: 52 · 2018: 70 · 2017: 74 · 2016: 78 · 2015: 81 · 2014: 89 · 2013: 91 · 2012: 97
- FWCI
- 50.74
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- Lund University Publications (Lund University) (submittedVersion)
- Funders
- National Institutes of Health
- U.S. Public Health Service (01527, 52711)
- National Institute on Aging (AG09464, P01AG009464)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- amyloid-beta, NMDA receptor trafficking, receptor internalization, Alzheimer's disease, glutamatergic neurotransmission, synaptic plasticity, gamma-secretase inhibitors, alpha7 nicotinic acetylcholine receptor, calcineurin, synaptic dysfunction, cortical neurons
- MeSH terms
- Alzheimer Disease, Animals, Cell Membrane, Cerebral Cortex, Disease Models, Animal, Electric Conductivity, Endocytosis, Enzyme Activation, Neurons, Nuclear Proteins, Peptide Fragments, Receptors, Nicotinic, Synapses, Signal Transduction, Trans-Activators, Receptors, N-Methyl-D-Aspartate, N-Methylaspartate, Amyloid beta-Peptides, Amyloid beta-Protein Precursor, Protein Tyrosine Phosphatases, Calcineurin, Protein Transport, CREB-Binding Protein, Mice, Protein Tyrosine Phosphatases, Non-Receptor, alpha7 Nicotinic Acetylcholine Receptor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.